Gastrointestinal stromal tumor revealed by hemorrhagic shock
Article Sidebar
Main Article Content
Abstract
Gastrointestinal Stromal Tumors (GISTs) are rare tumors of the digestive tract. The small intestine is the second most frequent localization of GIST after the stomach. We report a case of the ileal stromal tumor. The patient was admitted with a picture of hemorrhagic shock due to massive rectal bleeding. The fiberscope performed after stabilization was not objectified at the origin of the document while the CT scan objectified a mass of tissue density at the level of the right iliac fossa. Given the increasing evolution with the recurrence of patients to a target of a laparotomy for diagnostic and therapeutic purposes objectifying the tumor of the right iliac fossa at the expense of the ileum. The surgical procedure consisted of a major segmental resection of the tumor with ileo-ileal anastomosis. The anatomopathological study confirmed the diagnosis of the stromal tumor with good evolution. Through a general review of the literature, we have described the various clinical, para-clinical, anatomopathological, prognostic, and current therapeutic aspects specific to these tumors.
Downloads
Article Details
Copyright (c) 2022 Lemfadli Y, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Coindre JM, Emile JF, Monges G, Ranchère-Vince D, Scoazec JY (2005) Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy. Ann Pathol 25: 358-385. Link: https://bit.ly/3tG2QxT
Martí Obiol R, Garcés Albir M, López Mozos F, Ortega Serrano J (2013) Surgical treatment of gastrointestinal stromal tumours. Analysis of our experience. Cir Esp 91: 38-43. Link: https://bit.ly/3IUWXn6
Artigas Raventós V, López Pousa A, Ortega Medina L, de Liaño Argüelles AD, Fernández Hernández JA, et al. (2013) Primary, Non-metastatic Gastrointestinal Stromal Tumor Surgery: Results of the GRISK Study. Cir Esp 91: 96-102. Link: https://bit.ly/3HMue2x
Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, et al. (2001) KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61: 8118- 8121. Link: https://bit.ly/3CuHasD
Gupta P, Tewari M, Shukla HS (2008) Gastrointestinal Stromal Tumor. Surg Oncol 17: 129-138. Link: https://bit.ly/3sROefR
Balaton AJ, Coindre JM, Cvitkovic F (2001) Tumeurs stromales digestives. Gastroenterol Clin Biol 25: 473-482.
Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130: 1466-1478. Link: https://bit.ly/3Kkszmq
Tateishi U, Hasegawa T, Satake M, Moriyama N (2003) Gastrointestinal stromal tumor.correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr 27: 792-798. Link: https://bit.ly/3KnPf52
Serraj I, Amrani L, Atitar I, Kanouni N, Al Baroudi S, et al. (2008) Obscure gastrointestinal bleeding due to jejunal stromal tumor: the contribution of capsule endoscopy. Gastroenterol Clin Biol 32: 1022-1024.
Hueman MT, Schulick RD (2008) Management of gastrointestinal stromal tumors. Surg Clin North Am 88: 599–614. Link: https://bit.ly/3hUnSDH
Gleevec (imatinib mesylate) Prescribing information. Link: https://bit.ly/3i8pR7D
Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, et al. (2009) Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surgical Oncology 99: 42–47. Link: https://bit.ly/3vRsRgG